Skip to main content

Early Termination of the Diabetes Control and Complications Trial

  • Chapter
Data Monitoring in Clinical Trials

Abstract

The Diabetes Control and Complications Trial (1983–1993) of 1,441 subjects followed for an average of 6.5 years assessed the effects of intensive therapy aimed at maintaining near normal levels of blood glucose versus conventional therapy on the risks of diabetes complications of the eyes, kidneys, and nerves. The study was designed to test the hypothesis that the higher than normal blood glucose levels associated with conventional insulin therapy caused these complications. The study was terminated one year ahead of schedule by the monitoring board. This paper describes the medical, ethical, and statistical challenges faced by the study group and the monitoring board.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. DCCT Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986.

    Article  Google Scholar 

  2. Siebert C, Clark CM. 1993. Operational and policy considerations of data monitoring in clinical trials: The Diabetes Control and Complications Trial Experience. Control Clin Trials 14:30–44.

    Article  Google Scholar 

  3. DCCT Research Group. 1986. The Diabetes Control and Complications Trial (DCCT): Design and methodological considerations for the feasibility phase. Diabetes 35:530–545.

    Article  Google Scholar 

  4. DCCT Research Group. 1988. The Diabetes Control and Complications Trial (DCCT): Update. Diabetes Spectrum 1:187–190.

    Google Scholar 

  5. DCCT Research Group. 1990. The Diabetes Control and Complications Trial (DCCT): Update. Diabetes Care 13:427–433.

    Article  Google Scholar 

  6. DCCT Research Group. 1987. The Diabetes Control and Complications Trial (DCCT): Results of the feasibility study (Phase II). Diabetes Care 10:1–19.

    Article  Google Scholar 

  7. Early Treatment Diabetic Retinopathy Study Research Group. 1991. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House Classification: ETDRS report No.10. Ophthalmology 98:786–806.

    Google Scholar 

  8. Lachin JM. 2000. Statistical Considerations in the Intent-to-treat Principle. Control Clin Trials 21:167–189.

    Article  Google Scholar 

  9. Lachin JM, Foulkes MA. 1986. Evaluation of sample size and power for analyses of survival with allowance for non-uniform subject entry, losses to follow-up, non-compliance and stratification. Biometrics 42:507–519.

    Article  MATH  Google Scholar 

  10. Lan KKG, DeMets DL. 1983. Discrete sequential boundaries for clinical trials. Biometrika 70:659–663.

    Article  MathSciNet  MATH  Google Scholar 

  11. Lan KKG, DeMets DL. 1989. Group sequential procedures: Calendar versus information time. Stat Med 8:1191–1198.

    Article  Google Scholar 

  12. Wei LJ, Lachin JM. 1984. Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc 79:653–661.

    Article  MathSciNet  MATH  Google Scholar 

  13. Thall PF, Lachin JM. 1988. Analysis of recurrent events: Nonparametric methods for random interval count data. J Am Stat Assoc 83:339–347.

    Article  Google Scholar 

  14. Lachin JM. 1992. Some large sample size distribution-free estimators and tests for multivariate partially incomplete observations from two populations. Stat Med 11:1151–1170.

    Article  Google Scholar 

  15. Su JQ and Lachin JM. 1992. Group sequential distribution-free methods for the analysis of multivariate observations. Biometrics 48:1033–1042.

    Article  MATH  Google Scholar 

  16. Lachin JM. 1988. Statistical properties of randomization in clinical trials. Control Clin Trials 9:289–311.

    Article  Google Scholar 

  17. Wei LJ, Lachin JM. 1988 Properties of the Urn randomization in clinical trials. Control Clin Trials 9:345–364.

    Article  Google Scholar 

  18. Lachin JM. 2000. Biostatistical Methods: The Assessment of Relative Risks. John Wiley and Sons, New York.

    Book  MATH  Google Scholar 

  19. Lan KKG, Lachin JM and Bautista OM. 2003. Over-ruling a group sequential boundary-a stopping rule versus a guideline. Stat Med 22:3347–3355.

    Article  Google Scholar 

  20. DCCT Research Group. 1989. Implementation of a multi-component process to obtain informed consent in the Diabetes Control and Complications Trial. Control Clin Trials 10:83–96.

    Article  Google Scholar 

  21. The DCCT/EDIC Research Group. 2000. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342:381–389.

    Article  Google Scholar 

  22. The DCCT/EDIC Research Group. 2002. The effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563–2569.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Lachin, J.M. et al. (2006). Early Termination of the Diabetes Control and Complications Trial. In: DeMets, D.L., Furberg, C.D., Friedman, L.M. (eds) Data Monitoring in Clinical Trials. Springer, New York, NY. https://doi.org/10.1007/0-387-30107-0_9

Download citation

Publish with us

Policies and ethics